Google's life-extension biotech Calico has secured access to data held by Ancestry.com, a family tree business that sells DNA testing kits. Calico will pick through the genetic data and millions of family trees in search of contributors to long life spans and drug targets.
YouTube users upload 300 hours of video every minute. If the site keeps growing at its current rate, researchers think users could be uploading 1,700 hours of video a minute by 2025, a total that would amount to 2 exabytes of data per year. Yet if a new analysis is right, the computing crunch facing genomics could dwarf these challenges.
The 33.86-petaflops supercomputer, which has topped the table of the world's fastest machines since its introduction in 2013, was used to cut the time it took to detect single nucleotide polymorphisms.
Genomics England has named the four companies it wants to work with on the interpretation of the first 8,000 genomes from its massive sequencing effort. The list of successful bidders is lacking some big-name applicants, with Illumina and Qiagen among the companies to miss out.
A team at the University of California, San Diego (UCSD), has found biomarkers for ovarian tumors by mining two National Institutes of Health-sponsored databases. The bioinformatics-enabled research program has raised expectations that earlier diagnoses of ovarian cancer can be made, an advance that could improve outcomes in a tough therapeutic indication.
Genomics England has run into teething problems in the first few months of its massive genome sequencing initiative. About half of tumor samples sequenced to date have yielded substandard data, a shortcoming Genomics England is trying to overcome by trialing new processes and working with hospitals to incorporate the practices into their day-to-day tasks.
Israel has become the latest country to disclose plans to create a population-scale database of linked genetic and clinical records. The current plan is reminiscent of the United Kingdom's 100,000 Genomes Project, with Israel considering working with tech firms to create a database of patients with rare genetic diseases.
J. Craig Venter's Human Longevity Inc. (HLI) has struck a deal with the Cleveland Clinic to access blood samples. The initial focus of the deal is on the sequencing and analysis of samples in Cleveland Clinic's GeneBank.
GenomeDx Biosciences is making its pool of clinically annotated data on the genomics of urological cancers available to Sidney Kimmel Cancer Center.
AstraZeneca is digging through the genomes of 80,000 people in search of genes linked to cardiovascular diseases and diabetes. The project is a collaboration with the Montreal Heart Institute, which will genotype 80,000 samples from AstraZeneca's biobank of blood and tissue samples.